In 2011, the FDA approved Optune, another Novocure device for the treatment of a single type of brain cancer, a glioblastoma that uses electrical fields to prevent the division of solid tumors from mesothelioma, the Novocure NovoTTTTTTTF-100L system. May 24, 2019 – The FDA approved the first new treatment for aggressive lung cancer in 15 years. “In general, patients with mesothelioma who cannot be operated on receive palliative care to alleviate their symptoms,” “she” said in a statement. The new product was approved as part of a humanitarian exception that was created to promote innovation in rare diseases. Mesothelioma is a rare but aggressive form of cancer that is closely linked to asbestos. WebMD does not provide medical advice, diagnosis or treatment.